Pierre DaublainSenior Research Chemist Merck
Holly KimkoScientific Director Johnson & Johnson
Wojciech KrzyanskiAssistant Professor University of Buffalo
Lucy LeeClinical Pharmacologist Eisai
Tristan MaurerResearch Fellow Pfizer
Wei-Jian PanPrincipal Scientist Amgen
Andrew SteinSenior Modeller Novartis
Stacey TannenbaumDirector Astellas Pharmaceuticals
PK/PD represents the best opportunity to predict how a drug behaves before it enters the body. Drug developers already know this and are desperately trying to develop a best-in-class PK/PD strategy, ensuring that the best decisions are made moving into the clinic.
This conference will provide a forum to facilitate the exchange of practical information with the sole purpose of allowing you to implement the best PK/PD strategy possible, quickly.
The PK/PD Summit brings together speakers from Pfizer, Johnson & Johnson, Merck, Novartis, Amgen and others as they showcase new PK/PD strategies that you can adopt immediately on your return to the lab.
View the full range of topics to be discussed in the event brochure
With drug developers already adopting better PK/PD approaches, don’t run the risk of falling behind. Attend this meeting to meet the people who will enable you to improve your technical capabilities and gather more predictive data. Data that will lead to better decisions being made with more certainty on the outcome.
"Very valuable useful information - one of the best meetings I've ever attended" Millennium